Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy

Purpose The therapeutic benefit of a three-drug combination of antiemetics has not been established in moderately emetogenic chemotherapy (MEC). The aim of this study was to compare the antiemetic effectiveness and cost-saving of palonosetron plus dexamethasone (control group) with aprepitant, grani...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Toda, Haruka, Kawazoe, Hitoshi, Yano, Akiko, Yamamoto, Yuji, Watanabe, Yuji, Yamamoto, Yasunori, Hiasa, Yoichi, Yakushijin, Yoshihiro, Tanaka, Akihiro, Araki, Hiroaki
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2017
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5479242/
https://ncbi.nlm.nih.gov/pubmed/28638451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17102
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki